Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced an upcoming board meeting on October 25, 2024, to review and approve its third quarterly results for the period ending September 30, 2024. The announcement emphasizes the importance of the meeting for shareholders and the financial market, as the results will reflect the company’s performance and strategic direction.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.